Opening book details…
About this Medicine article
Efficacy and safety of pioglitazone in a phase 1/2 imatinib discontinuation trial (EDI‐PIO) in chronic myeloid leukemia with deep molecular response by Pagnano, Katia B.B.; Lopes, Ana Beatriz P.; Miranda, Eliana C.; Delamain, Márcia T.; Duarte, Gislaine O.; Rodrigues, Bruna R.V.; Povoa, Valquiria M.O.; Furlin, Graziele C.P.; Vianna, Jessica C.; Silva, Matheus A.S.; De Souza, Carmino A; De Paula, Erich V is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Pagnano, Katia B.B.; Lopes, Ana Beatriz P.; Miranda, Eliana C.; Delamain, Márcia T.; Duarte, Gislaine O.; Rodrigues, Bruna R.V.; Povoa, Valquiria M.O.; Furlin, Graziele C.P.; Vianna, Jessica C.; Silva, Matheus A.S.; De Souza, Carmino A; De Paula, Erich V
- Publisher
- John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley; Research Square (ISSN 0361-8609)
- Published
- 2020
- Field
- Medicine (Health Sciences)